
Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
A clinical-stage radiopharmaceutical company seeks a Nuclear Metrology Expert in Oslo to lead the technical design and execution of plans for Th228 and Pb212 measurement. The successful candidate will manage external manufacturing, support clinical trials, and ensure compliance with nuclear physics standards. A PhD in Nuclear Physics and extensive experience in radioactive material processes are required, alongside strong problem-solving and leadership skills. This role aims to uphold ARTBIO's commitment to innovative cancer care.
The Nuclear Metrology Expert will be responsible for the technical design, management, and execution of accurate plans for Th228 and its progenies, particularly Pb212 measurement, for targeted dose administration to the patient. The Expert will oversee our decentralized external manufacturing network and our internal R&D labs to support clinical trials and readiness for commercial deployment. The successful candidate will be an expert thinker with technical proficiency in nuclear physics and radiopharmaceutical development who will build a strong technical foundation around our strategic pillars, focused on our Pb212 candidate platform. In addition, the Nuclear Metrology Expert must have a profound understanding of the competitive landscape and the ability to integrate learnings and failures from others to improve the measurement standards obligation.
ARTBIO is a clinical‑stage radiopharmaceutical company redefining cancer care by creating a new class of alpha radioligand therapies (ARTs). The unique ARTBIO approach selects the optimal alpha‑precursor isotope (212Pb) and tumor‑specific targets to create therapeutics with the potential for highest efficacy and safety. The company’s AlphaDirect™ technology, a first‑of‑its‑kind 212Pb isolation method, enables a distributed manufacturing approach for the reliable production and delivery of ARTs. ARTBIO is advancing multiple pipeline programs with lead program AB001 currently in first‑in‑human trials. ARTBIO is shaped by a long‑standing scientific legacy with nearly a century of pioneering work in radiation therapy conducted at the University of Oslo and Norway’s Radium Hospital. For more information, visit www.artbio.com, and follow us on LinkedIn and Twitter.
As an emerging, global biotech with locations in Boston, Massachusetts, Basel, Switzerland, London, England and Oslo, Norway, we take advantage of diverse scientific depth and insights which makes ARTBIO a unique place to work. We are driven by a desire to do better for cancer patients, lowering the burden of toleration and safety while at the same time raising the bar on clinical efficacy and duration.
ARTBIO is proud to be an equal opportunity workplace and is an affirmative action employer. We are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or veteran status. If you have a disability or special need that requires accommodation, please let us know.
ARTBIO does not accept unsolicited resumes from external agencies or recruiters. Submission of a resume without a prior written agreement does not create any express or implied contract between ARTBIO and the agency. ARTBIO will not pay any fees related to unsolicited resumes.